Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.8M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
5.12M
-
Shares change
-
-1.7M
-
Total reported value, excl. options
-
$106M
-
Value change
-
-$41.2M
-
Put/Call ratio
-
2.05
-
Number of buys
-
17
-
Number of sells
-
-34
-
Price
-
$20.67
Significant Holders of EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) as of Q1 2024
73 filings reported holding EYPT - EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.12M shares
of 68.8M outstanding shares and own 7.44% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (1.38M shares), MORGAN STANLEY (1.34M shares), DEUTSCHE BANK AG\ (836K shares), Fiera Capital Corp (671K shares), PERCEPTIVE ADVISORS LLC (590K shares), LORD, ABBETT & CO. LLC (243K shares), JANE STREET GROUP, LLC (215K shares), NEW YORK STATE COMMON RETIREMENT FUND (199K shares), Bank of New York Mellon Corp (155K shares), and Squarepoint Ops LLC (139K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.